Screener
Guardant Health GH Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Guardant Health’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:16 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001576280-26-000026
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total Liabilities | 2,096,364 | 2,112,966 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ deficit: | ||
| Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, par value of $0.00001 per share; 350,000,000 shares authorized; 131,514,404 and 130,635,301 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 1 | 1 |
| Additional paid-in capital | 2,930,665 | 2,900,056 |
| Accumulated other comprehensive loss | (5,152) | (4,852) |
| Accumulated deficit | (3,106,587) | (2,994,512) |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Guardant Health's preferred stock, shares authorized?
- Guardant Health (GH) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Guardant Health's preferred stock, shares authorized changed year-over-year?
- Guardant Health's preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Guardant Health's preferred stock, shares authorized?
- Over 4 years (2021 to 2025), Guardant Health's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.
Ask your AI about Guardant Health's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude